KIMBERLY SMITH: Open Payments
NPI 1053402339 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,673 in 229 payments from 22 companies in 2025. Trend: 2023 $3,496 · 2024 $3,505 · 2025 $12,673
Speaker / faculty: $7,434Food & beverage: $4,616Travel & lodging: $538Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $5,817 |
| ABBVIE INC. | 73 | $4,485 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $425 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $324 |
| Madrigal Pharmaceuticals | 12 | $298 |
| Aimmune Therapeutics, Inc. | 9 | $262 |
| Ardelyx, Inc. | 8 | $173 |
| Phathom Pharmaceuticals, Inc. | 9 | $168 |
| Gilead Sciences, Inc. | 5 | $124 |
| PFIZER INC. | 5 | $87 |
Products named: TREMFYA, CREON, RINVOQ, XIFAXAN, ENTYVIO, REZDIFFRA, ZENPEP, IBSRELA.
Industry payments across TN — which companies pay providers there.
